Visus Therapeutics

Seattle, United States

Visus Therapeutics is a clinical-stage company developing innovative medicines.

$20.0M raised

Aug 2021

Debt Financing

Biotechnology Therapeutics

Top Investors

RTW InvestmentsEQT Life SciencesJohnson & Johnson InnovationWille Finance

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Visus Therapeutics

How much funding has Visus Therapeutics raised?

Visus Therapeutics has raised $20.0M in total funding. The most recent round was Debt Financing. The last funding was announced in August 2021.

Who are Visus Therapeutics's investors?

Visus Therapeutics's investors include RTW Investments, EQT Life Sciences, Johnson & Johnson Innovation, Wille Finance.

Where is Visus Therapeutics headquartered?

Visus Therapeutics is headquartered in Seattle, United States.

What does Visus Therapeutics do?

Visus Therapeutics is a clinical-stage company developing innovative medicines.

What stage is Visus Therapeutics at?

Visus Therapeutics is at the Debt Financing stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated August 10, 2021.

MLA

"Visus Therapeutics — Funding & Investors." VCBacked, August 10, 2021, https://www.vcbacked.co/company/visus-therapeutics. Accessed July 1, 2026.

APA

VCBacked. (2021). Visus Therapeutics — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/visus-therapeutics

Wikipedia (cite web)

{{cite web |title=Visus Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/visus-therapeutics |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated August 10, 2021.

Similar Companies in Biotechnology

View all

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K